Completed PHASE4 INTERVENTIONAL 2-arm NCT02905539

A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or Monofer (HOMe_aFers_1)

A Randomized, Double-blind Comparative Study Comparing Ferric Carboxymaltose (Ferinject) and Iron Isomaltoside 1000 (Monofer) for Iron Substitution in Iron-deficiency Anemia

Sponsor: Universität des Saarlandes

Conditions Anemia, Iron-Deficiency

Interventions Ferric Carboxymaltose Iron Isomaltoside 1000

Updated 9 times since 2017 Last updated: Nov 26, 2020 Started: Jul 31, 2016 Primary completion: Jun 30, 2020 Completion: Jun 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Anemia, Iron-Deficiency and is currently completed. Universität des Saarlandes leads this study, which shows 9 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Feb 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Feb 2021 [monthly]

Completed PHASE4
Dec 2020 — Jan 2021 [monthly]

Completed PHASE4

Status: Active Not Recruiting → Completed

▶ Show 4 earlier versions

Apr 2020 — Dec 2020 [monthly]

Active Not Recruiting PHASE4
May 2019 — Apr 2020 [monthly]

Active Not Recruiting PHASE4

Status: Recruiting → Active Not Recruiting
Jun 2018 — May 2019 [monthly]

Recruiting PHASE4
Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE4

First recorded

Jul 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universität des Saarlandes

Data source: Universität des Saarlandes

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Homburg, Germany